JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by León, D. A.
Right arrow Articles by Taylor, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by León, D. A.
Right arrow Articles by Taylor, S. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 45, Issue of November 7, 1997 pp. 28431-28437

A Stable alpha -Helical Domain at the N Terminus of the RIalpha Subunits of cAMP-dependent Protein Kinase Is a Novel Dimerization/Docking Motif*

(Received for publication, May 23, 1997, and in revised form, August 29, 1997)

Darryl A. León Dagger , Friedrich W. Herberg §, Poopak Banky and Susan S. Taylor par

From the Howard Hughes Medical Institute, Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California 92093-0654 and § Ruhr-Universität Bochum, Institute für Biochemie Supramolekularer Systeme, D-44780 Bochum, Germany

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

The RIalpha subunit of cAMP-dependent protein kinase is maintained as an asymmetric dimer by a dimerization motif at the N terminus. Based on resistance to proteolysis and expression as a discrete domain in Escherichia coli, this motif is defined as residues 12-61. This motif is chemically, kinetically, and thermally stable. The two endogenous interchain disulfide bonds between Cys16 and Cys37 in RIalpha are extremely resistant to reduction even in 8 M urea, indicating that they are well shielded from the reducing environment of the cell. The disulfide bonds were present in recombinant RIalpha as well as when the dimerization domain alone was expressed in E. coli, emphasizing the unusual stability of this motif and the disulfide bonds. Although 100 mM dithiothreitol was sufficient to reduce the disulfide bonds, it did not abolish dimerization. In addition, a stable dimer also still formed when Cys37 was replaced with His, confirming unambiguously the original antiparallel alignment of the disulfide bonds. Thus, both in vitro and in vivo, disulfide bonds are not required for dimerization. Circular dichroism of the dimerization domain indicated a high content of a thermostable alpha -helix. Based on the CD data, trypsin resistance of the fragment, location of the disulfide bonds, and amphipathic helix predictions, potential models are discussed. A new alignment of the dimerization domains of RI, RII, and cGMP-dependent protein kinase elucidates fundamental similarities as well as significant differences among these three domains.


INTRODUCTION

Many of the proteins that are involved in signal transduction such as protein kinases and transcription factors tend to be modular. Multiple domains with well defined structure and function are assembled into a single polypeptide, thus allowing for the well orchestrated and highly regulated cascade of signaling events.

The regulatory subunits of cAMP-dependent protein kinase have long been recognized as highly modular multifunctional proteins (1, 2). The separate domains and their functional independence were initially established as a consequence of their susceptibility to limited proteolysis. Recombinant approaches have subsequently further defined the features of the isolated domains (3-6). At the amino terminus, a dimerization domain maintains the R subunits1 as an asymmetric dimer. This region is followed by a variable region, often proline-rich and containing multiple phosphorylation sites (7-9). Next is the inhibitor site, an extended segment that resembles a protein substrate and binds to the active site of the catalytic subunit in the absence of cAMP, thus maintaining the complex as an inactive tetramer. Because of its susceptibility to proteolysis in the absence of the catalytic subunit, this region is often referred to as the "hinge" region. At the C terminus are two tandem cAMP binding sites. Upon cooperative binding of cAMP to the R subunit, the active catalytic subunits are released from the holoenzyme complex. Although much is known about the function and structure of the cAMP binding sites, less is known about the dimerization domain (1, 4, 10). In the case of the RII subunit and more recently RI, this dimerization domain is thought to be important for subcellular localization (2, 11).

There are at least four unique gene products in the R subunit family, and all retain the same general domain structure. With the exception of the R subunit in Dictyostelium discoideum (12), all of the R subunits are stable dimers, and it is the amino terminus that is responsible for dimerization. The interaction site between the two protomers is associated with the first 40-60 residues, although the precise boundaries of the dimerization domain differ slightly for RI and RII subunits (13-15). Within the family of R subunits, the sequences at the amino terminus are the most variable. The two general classes are designated as RI and RII, and within each class are at least two variants, alpha  and beta  (1). In the RIalpha subunit, the dimer region contains two cysteine residues, which form interchain disulfide bonds (13). Since Cys16 is disulfide-bonded to Cys37, the two protomers were predicted to be antiparallel (16).

In the case of the RII subunit, the N-terminal dimerization domain has been implicated in a critical biological function, namely interaction with AKAPs (A-kinase anchor proteins) (2, 17-20) While anchoring proteins so far have been associated primarily with the RII subunits, a recent finding shows that a novel family of anchoring proteins recognizes RI as well as RII (11), indicating that the RI subunit is likely to play a role in subcellular targeting of cAPK. Other reports that the RI subunit localizes to the activated T-cell receptor and the neuromuscular junction lend further support to such a role for RI in addition to its role as an inhibitor of the catalytic subunit of cAPK (21, 22).

The RIalpha dimerization domain, expressed as a stable disulfide-bonded, trypsin-resistant fragment, is described here with particular focus on the importance of the endogenous interchain disulfide bonds. Biophysical analysis of the reduced fragment as well as mutation of Cys37 confirmed the antiparallel alignments of the chains and established, furthermore, that disulfide bonds are not required for dimerization in vitro or in vivo. Models of the dimerization/docking domain of RIalpha are discussed and compared with the RII subunit as well as cGMP-dependent protein kinase.


EXPERIMENTAL PROCEDURES

Expression and Purification of RIalpha

The bovine RIalpha was expressed and purified as described previously (23).

Mutagenesis, Expression, and Purification of Mutant Proteins

To confirm the antiparallel alignment of the protomers and to ascertain the importance of the disulfide bonds for dimerization, Cys37 was replaced with His using the in vitro mutagenesis system from Bio-Rad, which is based on the Kunkel method (24) as described previously. The resulting clones containing the mutant DNA were identified by sequencing using the Sanger dideoxy method (25). The mutant double-stranded DNA was transformed into Escherichia coli 222 cells and grown on LB/ampicillin agar plates. Cells were grown and checked for protein expression using SDS-PAGE. The mutant recombinant RIalpha -(C37H) was purified by ion-exchange chromatography on DEAE-cellulose (23).

To determine whether the N-terminal domain could be expressed independently as a stable disulfide-bonded dimer, two stop codons were introduced at Gln62 in the RIalpha subunit as described above. To facilitate purification, the deletion mutant was also fused to a polyhistidine tag in the pRSETc vector. The Q62stopRI gene was excised from the RIalpha :pUC118 vector using EcoRI and subcloned into the pRSETc vector. The recombinant DNA was transformed into E. coli BL21(DE3) competent cells. Expression was tested in the absence and presence of 0.4 mM isopropyl-beta -D-thiogalactopyranoside by SDS-PAGE.

Conditions Required for Reduction of Interchain Disulfide Bonds

The RIalpha subunit (2 mg/ml) was incubated for 1 h with increasing concentrations of dithiothreitol (DTT) (0-100 mM). Samples were then boiled for 2 min in sample buffer (2.5% SDS, 10% glycerol, and 0.01% bromphenol blue) and subjected to SDS-PAGE. Slab gels (1 mm) were prepared with 10% acrylamide as described by Laemmli (26). In some cases, N-ethylmaleimide (NEM) at a final concentration of 1 M was added to quench the reaction prior to the addition of the denaturing SDS solution to guarantee that no reduction occurred following denaturation. Samples were also unfolded in the presence of 8 M urea. RIalpha (2 mg/ml) was dialyzed against 8 M urea, 10 mM MOPS (pH 7.0) for 2 h and then incubated with increasing amounts of DTT. The effect of quenching the reaction with NEM prior to the addition of the denaturing SDS solution was also evaluated.

Expression and Purification of the N-terminal Peptide (Amino Acids 12-61) of RIalpha

The Q62stopRI gene was subcloned from puc118 into pRSETc-EcoRI. The fusion protein designated His6-RI(1-61) was expressed in E. coli BL21(DE3) at 37 °C and purified to near homogeneity using cobalt-agarose resin. Bacterial cell lysates containing His6-RI-(1-61) were incubated with cobalt-agarose in lysis buffer (20 mM Tris-HCl, 100 mM NaCl, pH 8.0) with 5 mM beta -ME at 4 °C for 1 h and then washed with the same buffer with 10 mM imidazole to remove nonspecifically bound proteins. His6-RI-(1-61) was then eluted off the resin with lysis buffer containing 100 mM imidazole. After dialyzing against 50 mM ammonium bicarbonate overnight at 4 °C, the fusion protein was digested with TPCK-treated trypsin (1:50, w/w) for 20 h at 37 °C. Peptides were then resolved by HPLC on a Vydac C18 column (1.0 × 25 cm) using a 10-50% gradient at pH 2.1 of buffer A (0.1% trifluoroacetic acid) and buffer B (0.08% trifluoroacetic acid in 95% acetonitrile). The flow rate was 3 ml/min, and absorbance was monitored at 219 nm. The fraction containing the disulfide-bonded fragment of RIalpha comprising residues 12-61 was thus isolated.

The amino acid sequence of the N-terminal peptide was determined using an automated ABI gas phase peptide sequencer. Protein concentration was determined by amino acid analysis and/or Coomassie protein assay reagent (Pierce).

Analytical Gel Filtration

Analytical gel filtration was carried out using a Superdex 75 HR 10/30 column with a flow rate of 0.8 ml/min at 22 °C in a MOPS buffer (20 mM, pH 7.0) containing 100 mM KCl with Pharmacia fast protein liquid chromatography. The retention volume of RIalpha in the absence of DTT was compared with RIalpha that had been pretreated in the MOPS/KCl buffer containing 100 mM DTT.

To determine the molecular weight of the dimerization domain, RI-(12-61), the protein was loaded onto the Superdex 75 HR 10/30 column at an initial concentration of 1 mg/ml. The column was calibrated using the Pharmacia calibration kit.

Circular Dichroism

The lyophilized dimerization domain, RIalpha -(12-61), (0.14 mg) was redissolved in 1 ml of 25 mM potassium phosphate and 2 mM EDTA, pH 6.8, and placed in a cuvette with a 0.2-cm path length. Circular dichroism measurements were made on an AVIV CD spectropolarimeter. The spectrum was scanned from 300 to 200 nm at the temperatures indicated. The mean residue ellipticity, [theta ], was calculated as theta /lCr where theta  is the ellipticity in degrees, l is the cell path length in cm, and Cr is the concentration of amino acid residues in dmol/liter.

Prediction of Secondary Structure

To further analyze the secondary structure of the dimerization domain, the sequence of the trypsin-resistant segment was analyzed using the CDESTIMA computer program, which combines the CD data with the Chou-Fasman algorithm (27).


RESULTS

Conservation of Interchain Disulfide Bonds in Recombinant RIalpha

When the RIalpha subunit of cAPK was purified from mammalian tissues, the two protomers of the dimer were stoichiometrically cross-linked by interchain disulfide bonds (13). No significant amount of monomer was observed in the absence of beta -ME. As seen in Fig. 1, when the RIalpha subunit and a deletion mutant, RI-(Delta 260-379), were overexpressed in E. coli, the protomers were also totally cross-linked by interchain disulfide bonds just as was observed for the full-length mammalian RIalpha subunit. To confirm that these disulfide bonds were not formed as an artifact during purification, the total extract was lysed directly in SDS-PAGE buffer. Under these conditions, the two protomers were still stoichiometrically linked by interchain disulfide bonds. No monomeric R subunit was observed.


Fig. 1. SDS-PAGE analysis of the dimeric and monomeric forms of the RI subunit. E. coli lysate containing RI (lanes 1 and 2), purified RI (lanes 3 and 4), and purified RI-(Delta 260-379) (lanes 5 and 6) were incubated without (-) and with (+) beta -mercaptoethanol and then boiled for 2 min before loading on a 10% SDS-PAGE. The dimer and monomer forms of the RI subunits are indicated with arrows.

[View Larger Version of this Image (28K GIF file)]


Stability of the Endogenous Disulfides in the RIalpha Dimer

The stability of these interchain disulfide bonds in RIalpha was assessed first by defining the conditions required for reducing the disulfide linkage. The RIalpha dimer was incubated for 1 h at room temperature with increasing concentrations of DTT. Reduction was monitored by nonreducing SDS-PAGE. Excess DTT was quenched by adding 1 M NEM prior to adding the sample to the SDS denaturing solution. As seen in Fig. 2A, significant amounts of monomer were only observed when the concentration of DTT was 50 mM or greater. Even in the absence of NEM, the full disappearance of the dimer required 50 mM DTT (Fig. 2B).


Fig. 2. Conditions required for reduction of the interchain disulfide bonds. A, the positions of the regulatory subunit monomer (M) and dimer (D) are indicated by arrows. Aliquots of RIalpha (2 mg/ml) were incubated with increasing concentrations of DTT. The reactions were quenched with 1 M NEM and then boiled for 2 min in SDS sample buffer before loading. Concentrations of DTT are indicated above each lane. B, aliquots of RIalpha (2 mg/ml) were incubated with increasing concentrations of DTT. The reactions were boiled for 2 min in SDS sample buffer. DTT concentrations are indicated above each lane. C, aliquots of RIalpha that had been dialyzed against M urea were incubated with increasing concentrations of DTT. Reactions were quenched with 1 M NEM and then boiled for 2 min in SDS sample buffer before loading. DTT concentrations are indicated above each lane. D, aliquots of RIalpha that had been dialyzed against M urea were incubated with increasing concentrations of DTT. These reactions were boiled for 2 min in SDS sample buffer before loading. DTT concentrations are indicated above each lane.

[View Larger Version of this Image (38K GIF file)]


To determine whether denatured RIalpha could be reduced more readily than the native protein, the RIalpha dimer was unfolded by dialyzing against 8 M urea before adding DTT. Under these conditions, the three tryptophans in RIalpha , located in cAMP-binding domains, are fully exposed to solvent based on iodide quenching (28). The addition of 8 M urea had no effect on the reduction of the disulfide bonds when excess DTT was quenched with NEM (Fig. 2D). Even in the presence of 8 M urea, 50 mM DTT was still required to reduce the interchain disulfide bonds. In the absence of quenching with NEM, some monomer was observed at DTT concentrations of 5 mM; however, this most likely occurred after the addition of the SDS denaturing buffer (Fig. 2C).

The above results indicated that the disulfide bonds in the RIalpha dimer were extremely resistant to reduction. Even when the rest of the molecule was exposed to 8 M urea, a condition sufficient to unfold the cAMP-binding domains (28), the disulfides in the dimerization domain remained protected, suggesting that the secondary structure in the disulfide-bonded segment was still intact.

Expression of the Dimerization Domain

To further probe the stability and structural features of this dimerization motif, recombinant techniques were used to overexpress a deletion mutant of RIalpha that contained only the dimerization region. The N-terminal fragment was overexpressed and purified using the cobalt-agarose affinity resin.

Fractions containing His6-RI-(1-61) were then pooled and digested with TPCK-treated trypsin. The tryptic peptide corresponding to residues 12-61 was purified by HPLC as described under "Experimental Procedures." Fig. 3 shows the purified fusion protein as well as the final trypsinized peptide analyzed on SDS-PAGE under reducing as well as nonreducing conditions. The apparent molecular mass for the monomer was 9.0 kDa. In the absence of beta -ME, the purified fragment ran with a apparent molecular mass of 18 kDa. Thus, the peptide alone, like the intact RIalpha , is a stable disulfide-bonded dimer. The tryptic peptide was analyzed by analytical gel filtration column in KMOPS buffer (20 mM MOPS, 100 mM KCl, pH 6.5). Under these conditions, the apparent molecular mass was calculated to be 17 kDa based on constructed calibration curves.


Fig. 3. SDS-PAGE analysis of purified RI-(12-61). A 17.5% gel was loaded with eluate from the cobalt-agarose resin in the presence (lane 1) and absence of beta -ME (lane 2); purified tryptic peptide RI-(12-61) is shown in lane 3 in the absence of beta -ME and in lane 4 in the presence of beta -ME.

[View Larger Version of this Image (64K GIF file)]


Importance of the Disulfide Bonds for Dimerization

When the RIalpha dimer was analyzed by gel filtration in the absence of DTT, it eluted as an asymmetric dimer with a Stokes radius of 46.3 Å (29). Pretreatment of the RI subunit with 100 mM DTT for 1 h was sufficient to achieve complete reduction of the disulfide bonds as shown by SDS-PAGE (Fig. 2). When this protein was loaded onto the gel filtration column equilibrated with 100 mM DTT in the running buffer, the elution volume was unchanged, indicating that the dimer was intact although the interchain disulfide bonds were no longer present.

Antiparallel Alignment of the Protomers

To confirm that the chains were aligned in an antiparallel arrangement and to further determine whether the disulfide bonds were necessary for a stable dimer, Cys37 was replaced with His. This Cys37 right-arrow His mutant migrated on SDS-PAGE in the absence or presence of reducing agent as a monomer (Fig. 4, inset). When analyzed by gel filtration, however, recombinant RIalpha -(C37H) still migrated as a dimer and was indistinguishable from the wild type RIalpha (Fig. 4). The finding that the mutation of a single Cys, C37H, abolished the interchain disulfide bonds thus confirmed the previous observation that the two monomers are aligned in an antiparallel orientation and also established that the disulfide bonds are not essential for stable dimer formation in vivo.


Fig. 4. Gel filtration of wild type RIalpha and mutant RIalpha -(C37H). Wild type RIalpha (200 µl; solid lines) and mutant RIalpha -(C37H) (dashed lines) were chromatographed on a Superdex 75 HR 10/30 column. The inset shows a 15% SDS gel. Lane 1, wild type RIalpha (25 mM DTT); lane 2, wild type RIalpha (50 mM DTT); lane 3, wild type RIalpha (100 mM DTT); lane 4, RIalpha -(C37H) (0 mM DTT); lane 5, RIalpha -(C37H) (100 mM DTT).

[View Larger Version of this Image (33K GIF file)]


Circular Dichroism of the Isolated Dimerization Domain

The CD spectrum for the RIalpha -(12-61) dimerization domain (Fig. 5) showed two minima at 205 and 222 nm, indicating a high content of alpha -helix. The alpha -helicity of the peptide was monitored over a wide pH range. The peptide was stable to pH changes and still maintained a considerable amount of secondary structure at extremes of pH (2 and 12).


Fig. 5. Circular dichroic spectra of RIalpha -(12-61). A, the peptide fragment (0.14 mg) was dissolved in 25 mM potassium phosphate buffer and 2 mM EDTA, pH 6.8. B, CD scans were taken in the presence of either 100 mM or 1 M potassium fluoride. C, the peptide fragment (0.14 mg) was dissolved in 25 mM potassium phosphate buffer and 2 mM EDTA, pH 6.8. The temperature was increased from 0 to 92 °C. The spectrum corresponds to a sample that was incubated at 92 °C and then allowed to renature at room temperature. Measurements were carried out in duplicate after raising the temperature by 3 °C increments. The spectra for selected temperatures are shown in the top: 0 °C (open circle ), 26 °C (square ), refolded 25 °C (black-square), 62 °C (black-diamond ), and 92 °C (triangle ). The temperature versus ellipticity at 222 nm is shown at the bottom.

[View Larger Version of this Image (31K GIF file)]


Based on the amino acid sequence of the RIalpha N-terminal domain, it is speculated that hydrophobic interactions are critical in mediating interfacial packing at the dimeric interface. To test this hypothesis, CD spectra of the N-terminal peptide were taken at 100 mM and 1 M potassium fluoride. As shown in Fig. 5B, at higher ionic strength there is an increase in the alpha -helicity of the peptide, confirming that, in fact, hydrophobic interactions are important.

The thermal stability of the RIalpha -(12-61) fragment was also monitored by CD. The spectra were scanned from 300 to 200 nm, and the temperature was increased from 0 to 92 °C. CD spectra at selected temperatures are shown in Fig. 5C. From 0 to 62 °C, there was a gradual loss of ellipticity, yet at both temperatures, there was still defined alpha -helical structure. A spectrum typical of a random coil was not observed even at 92 °C, indicating that secondary structure was still present. A complete temperature curve is shown in Fig. 5C. After RIalpha -(12-61) was incubated at 92 °C, it was allowed to cool to room temperature (25 °C). The spectrum of the refolded RIalpha -(12-61) was very similar to the original spectrum at 26 °C, indicating that the partial unfolding of dimeric fragment was fully reversible.

Secondary Structure Prediction

Based on the CDESTIMA program, which couples the CD data with a Chou-Fasman algorithm, the RIalpha -(12-61) dimeric fragment was predicted to be approximately 40-50% helical at 0 °C (Table I). Boundaries of the predicted helices are indicated in Fig. 6.

Table I. Calculated secondary structure from circular dichroic data

A convolution method was used based on the circular dichroic measurement data. The program CDESTIMA was used to estimate secondary structure from the data by incorporating the Chou-Fasman algorithm.

Temperature  alpha -Helix  beta -structure Turn Random

% % % %
0 °C 46 5 22 27
26 °C 37 15 21 27
92 °C 15 28 26 31
Renatured at 25 °C 36 19 22 23


Fig. 6. Schematic representation of RIalpha subdomains. The domains of the RI subunit are indicated. Specifically, the dimerization domains are indicated with slanted lines, the pseudoinhibitor site is dotted, and the cAMP binding sites are indicated with different shadings of gray. The sequence of the peptide fragment of RIalpha (residues 12-61) that is isolated after trypsin digestion is shown below, followed by the secondary structure predictions based on the CDESTIMA program. The secondary structure motifs are labeled as follows: alpha -helix (spirals), beta -strand (arrows).

[View Larger Version of this Image (15K GIF file)]



DISCUSSION

The RIalpha subunit of cAPK is maintained as a dimeric protein by a dimerization domain at the N terminus. As demonstrated here, this domain is mostly helical and is chemically, kinetically, and thermally stable. Although disulfide bonding is rare in intracellular proteins, the RIalpha subunit is an exception, since the full-length mammalian and recombinant proteins expressed in E. coli were both found exclusively as disulfide-bonded dimers. Even when deletion mutants of the dimerization domain alone were expressed in E. coli, the two chains were still disulfide-bonded. The disulfide bonds were, furthermore, extremely resistant to reduction, even in the presence of 8 M urea, suggesting that these disulfide bonds are buried and shielded from solvent. The boundaries of the trypsin-resistant core that define this stable dimerization domain are indicated in Fig. 6.

Although the disulfide bonds were chemically stable, once reduced, the protein did not dissociate into monomers. It remained as a dimer with a Stokes radius that was indistinguishable from that of the wild type protein. To determine whether the disulfide bonds were required for dimerization in vivo, a mutant protein was engineered where one of the two cysteines was replaced with His. This mutation, C37H, was sufficient to abolish disulfide bonding, confirming the antiparallel alignment of the two chains that was shown previously by peptide mapping (16). This mutation was not, however, sufficient to prevent dimerization. Thus, like the RII subunits that lack interchain disulfide bonds, the RIalpha subunit is intrinsically a stable dimer, independent of the interchain disulfide bonds.

In the absence of a high resolution structure, the structural features of this dimerization domain were probed by CD, which indicated a high degree of a thermostable alpha -helix. Based on the CD spectrum of the isolated dimerization domain, the proteolytic resistance of the fragment, the resistance of the disulfide bonds to reduction, and secondary structure predictions, it is possible to propose a model for the tertiary structure of the dimerization motif, RIalpha -(12-61). The circular dichroism coupled with secondary structure prediction algorithms was used as a guide for localizing potential amphipathic helices. Residues 45-59, preceded by prolines, are predicted to be a well defined amphipathic alpha -helix. The N-terminal portion is predicted to contain an additional alpha -helix as well as two beta -strands. If the segment between Cys16 and Cys37 is predominantly helical, then the two chains must be antiparallel, to accommodate interchain disulfide bonding between Cys16 and Cys37. This would mean that the predicted helices at the C terminus would also be antiparallel, yielding a four-helix bundle motif. If, however, the segment between Cys16 and Cys37 contains both alpha -helix and beta -strand, the predicted C-terminal helix could be parallel, antiparallel, or not interacting at all. From the information described here, we know only that the residues within amino acids 16 and 37 are shielded from the solvent based on the stability of the disulfides and the protease resistance of the fragment.

The stability of the RIalpha dimeric domain is surprising but not unique for helical dimerization motifs. For instance, many DNA-binding proteins have a unique alpha -helical region that contains a characteristic heptad repeat of leucine residues referred to as a leucine zipper. The motif is found in transcription factors (i.e. GCN4) and in nuclear transforming oncogene products such as Fos, Jun, and Myc (30). The stability of these domains has been addressed thermodynamically (31) and in fact correlates with the remarkable thermal stability we observe for the RIalpha dimerization domain. Despite the similarity of the RIalpha dimerization domain in terms of stability with other known dimerization domains, we believe that the RIalpha dimerization domain is a novel and unique motif. Further experiments are under way to probe this domain structurally.

Is this dimerization motif in RIalpha conserved in other related members of this enzyme family? Two other members of this family, cGMP-dependent protein kinase (cGPK) and the RII subunits, are both stable dimers. The N-terminal sequences of all three proteins are compared in Fig. 7. The RII subunits, like cGPK and the RI subunits, are stable dimers, although they do not have interchain disulfide bonds. Previous alignments of the RI and RII subunits were based on the obvious sequence similarities in the cAMP-binding domains and in the autoinhibitor sites (32, 33). Similarities in these regions are extensive, with the major difference being that the RI subunits are typically about 20 residues shorter than the RII subunits due to a truncation of cAMP-binding domain B. Based on this original alignment, the sequence similarities in the amino terminus were not initially apparent (16). However, if the two molecules are aligned as shown in Fig. 7, where the predicted functional dimerization domains of RI and RII are aligned, similarities in the dimerization domains can also be recognized. For example, the type II holoenzyme, but not free RII, was susceptible to proteolysis at Arg45, and removal of these first 45 residues was sufficient to eliminate dimerization of this protein (14). This suggests that the region flanking Arg45 in the RII subunit must be on the surface, since it is accessible to trypsin. This protease-sensitive region is in the exact location as the protease-accessible site in the RI subunit (Ser12-Lys61) when the sequences are aligned as shown in Fig. 7. When the first 50 residues from the RII subunit were subjected to the CON22 program, which predicts secondary structure based on Chou-Fasman and Garnier algorithms (27, 34), one major alpha -helical region was identified, residues 27-45. In the alignment shown in Fig. 7, this segment now aligns with the predicted carboxyl-terminal helix in the dimerization domain of RIalpha .


Fig. 7. Sequence comparison of cGMP-dependent protein kinase and the RI and RII subunits of cAMP-dependent protein kinase. The similar hydrophobic amino acids are highlighted. The leucine/isoleucine heptad repeat in cGPK is marked with dots. The dimerization domains in these three proteins are enclosed in boxes. The cysteine pairs that are involved in disulfide bond linkage are shown with arrows.

[View Larger Version of this Image (25K GIF file)]


The dimerization domain in RIIalpha has a unique functional role. Within this segment is an "anchoring" motif that enables the RII subunit to bind with high affinity to other proteins such as the brain protein, p75 (35), and the microtubule assembly protein 2 (36-38). Disruption of the dimer is sufficient to abolish this binding. Residues 1-79 of the RII subunit, for example, are required for microtubule assembly protein 2 interaction, and removal of the first 10 residues was sufficient to abolish microtubule assembly protein 2 binding (39). It was concluded that dimerization was required for anchoring protein interactions and that residues 1-14 are an essential part of the dimerization domain in the RIIalpha subunit (15, 40, 41). Indirect evidence that residues 1-30 in the RIIalpha subunit have an amphipathic surface comes from the results of Carr et al., who concluded that the RIIalpha dimer interacts with anchoring proteins (microtubule assembly protein 2, P150, and two thyroid proteins) that contain a 14-residue amphipathic helix (42, 43). Scott and co-workers (2, 18) have identified a whole family of RIIalpha -binding proteins (AKAPs) that bind to overlapping regions of the extreme N-terminal dimerization domain of RIIalpha , and their binding is dependent on dimerization of RIIalpha . Recently, Li and Rubin (44) have identified key hydrophobic residues (Leu13, Phe36) that are essential for dimerization of RIIbeta and its subsequent anchoring to the cytoskeleton. These residues are conserved among all species as highlighted in Fig. 7, and their role as key hydrophobic contacts at the dimer interface is consistent with our model of the dimerization motif in RIalpha .

Recently, another novel anchoring protein was identified that can recognize both RI and RII. His6-RI-(12-61) was able to interact with this protein with high affinity (11). Although previous reports indicate that the RIalpha subunit localizes to activated T-cell receptors and is also localized at the neuromuscular junction (21, 22), this report is the first direct evidence showing that the N terminus of RI, like RII, can play a role in subcellular localization. Experiments are in progress to establish critical residues in the RI dimerization domain that are required for dimerization as well as binding to this novel family of anchoring proteins.

In cGMP-dependent protein kinase, the regulatory and catalytic domains are fused into a single polypeptide chain. Like cAPK, the two protomers are joined covalently, but there is only one interchain disulfide bond (45). An amino-terminal, 39-residue peptide of cGMP-dependent protein kinase was isolated and, based on circular dichroism and NMR analysis, was also found to be predominantly alpha -helical (46). cGMP-dependent protein kinase contains a leucine/isoleucine heptad repeat consistent with a leucine zipper motif (47). Although cAMP-dependent protein kinase and cGMP-dependent protein kinase have similar regulatory domains, the RIalpha dimerization domain does not contain an exact leucine/isoleucine heptad repeat like cGPK. In addition, there are prolines in the middle of the RIalpha dimerization domain. In theory, the leucine zipper in cGPK could be parallel or antiparallel; however, the single disulfide bond involving a Cys at the end of the dimerization motif in the alpha  isoform of cGPK makes it likely that this segment of the helical dimerization motif is parallel in cGPK (48). In contrast, the linking of Cys16 in one chain with Cys37 in the other chain mandates that this amino-terminal segment of the dimerization motif must be antiparallel in RIalpha . Thus, although both related proteins have a stable helical dimerization motif, there are some striking differences. The orientation of the rest of the molecule, in each of the dimerization domains discussed above, depends critically on the directionality of the C-terminal helix in each of them. This detailed comparison of the N-terminal domains of RI, RII, and cGMP-dependent protein kinase emphasizes that there are some fundamental similarities and differences among the three proteins, although all contain a well defined motif for maintaining a dimeric aggregation state. Ultimately, high resolution structures are necessary to define these differences.


FOOTNOTES

*   This work was supported in part by U.S. Public Health Service Grant GM34921.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Supported in part by a Department of Education Graduate Assistance in Areas of National Need Fellowship.
   Supported by a Patricia Harris fellowship.
par    To whom correspondence should be addressed: Howard Hughes Medical Inst., Dept. of Chemistry and Biochemistry, 0654, University of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0654.
1   The abbreviations used are: R subunit, regulatory subunit; RI and RII, type I and II regulatory subunits, respectively; beta -ME, beta -mercaptoethanol; DTT, dithiothreitol; NEM, N-ethylmaleimide; PAGE, polyacrylamide gel electrophoresis; MOPS, 3-(N-morpholino)propanesulfonic acid; cAPK, cAMP-dependent protein kinase; cGPK, cGMP-dependent protein kinase; PBS, phosphate-buffered saline; TPCK, L-1-tosylamido-2-phenylethyl chloromethyl ketone; HPLC, high pressure liquid chromatography.

ACKNOWLEDGEMENTS

We thank Siv Garrod at University of California San Diego (UCSD) for technical assistance in peptide isolation and sequencing, Patricia Jennings in the Department of Chemistry and Biochemistry (UCSD) for guidance in CD instrumentation, and Steve Smith at UCSD for technical services in amino acid analysis.


REFERENCES

  1. Taylor, S. S., Buechler, J. A., and Yonemoto, W. (1990) Annu. Rev. Biochem. 59, 971-1005 [CrossRef][Medline] [Order article via Infotrieve]
  2. Scott, J. D., and McCartney, S. (1994) Mol. Endocrinol. 8, 5-11 [CrossRef][Medline] [Order article via Infotrieve]
  3. Herberg, F. W., Dostmann, W. R. G., Zorn, M., Davis, S. J., and Taylor, S. S. (1994) Biochemistry 33, 7485-7494 [CrossRef][Medline] [Order article via Infotrieve]
  4. Shabb, J. B., and Corbin, J. D. (1992) J. Biol. Chem. 267, 5723-5726 [Free Full Text]
  5. Ringheim, G. E., and Taylor, S. S. (1990) J. Biol. Chem. 265, 4800-4808 [Abstract/Free Full Text]
  6. Bubis, J., and Taylor, S. S. (1987) Biochemistry 26, 3478-3486 [CrossRef][Medline] [Order article via Infotrieve]
  7. Weldon, S. L., Mumby, M. C., Beavo, J. A., and Taylor, S. S. (1983) J. Biol. Chem. 258, 1129-1135 [Abstract/Free Full Text]
  8. Hemmings, B. A., Aitken, A., Cohne, P., Raymond, M., and Hofmann, F. (1982) Eur. J. Biochem. 127, 473-481 [Medline] [Order article via Infotrieve]
  9. Carmichael, D. F., Geahlen, R. L., Allen, S. M., and Krebs, E. G. (1982) J. Biol. Chem. 257, 10440-10445 [Abstract/Free Full Text]
  10. Weber, I. T., Steitz, T. A., Bubis, J., and Taylor, S. S. (1987) Biochemistry 26, 343-351 [CrossRef][Medline] [Order article via Infotrieve]
  11. Huang, L. J., Durick, K., Weiner, J. A., Chun, J., and Taylor, S. S. (1997) J. Biol. Chem. 272, 8057-8064 [Abstract/Free Full Text]
  12. Mutzel, R., Lacombe, M.-L., Simon, M. N., deGunzburg, J., and Veron, M. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 6-10 [Abstract/Free Full Text]
  13. Zick, S. K., and Taylor, S. S. (1982) J. Biol. Chem. 257, 2287-2293 [Abstract/Free Full Text]
  14. Reimann, E. M. (1986) Biochemistry 25, 119-125 [CrossRef][Medline] [Order article via Infotrieve]
  15. Scott, J. D., Stofko, R. E., McDonald, J. R., Comer, J. D., Vitalis, E. A., and Mangili, J. A. (1990) J. Biol. Chem. 265, 21561-21566 [Abstract/Free Full Text]
  16. Bubis, J., Vedvick, T. S., and Taylor, S. S. (1987) J. Biol. Chem. 262, 14961-14966 [Abstract/Free Full Text]
  17. Rubin, C. S. (1994) Biochim. Biophys. Acta 1224, 467-479 [Medline] [Order article via Infotrieve]
  18. Dell'Acqua, M. L., and Scott, J. D. (1997) J. Biol. Chem 272, 12881-12884 [Free Full Text]
  19. Faux, M. C., and Scott, J. D. (1996) Cell 85, 9-12 [CrossRef][Medline] [Order article via Infotrieve]
  20. Faux, M. C., and Scott, J. D. (1996) Trends Biochem. Sci. 21, 312-315 [CrossRef][Medline] [Order article via Infotrieve]
  21. Skalhegg, B. S., Tasken, K., Hansson, V., Huitfeldt, H. S., Jahnsen, T., and Lea, T. (1994) Science 263, 84-87 [Abstract/Free Full Text]
  22. Imaizumi-Scherrer, T., Faust, D. M., Benichou, J.-C., and Weiss, M. C. (1996) J. Cell Biol. 134, 1241-1254 [Abstract/Free Full Text]
  23. Saraswat, L. D., Filutowics, M., and Taylor, S. (1988) Methods Enzymol. 159, 325-336 [Medline] [Order article via Infotrieve]
  24. Kunkel, T. A. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 488-492 [Abstract/Free Full Text]
  25. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74, 5463-5467 [Abstract/Free Full Text]
  26. Laemmli, U. K. (1970) Nature 227, 680-685 [CrossRef][Medline] [Order article via Infotrieve]
  27. Chou, P. Y., and Fasman, G. D. (1974) Biochemistry 13, 222-245 [CrossRef][Medline] [Order article via Infotrieve]
  28. León, D. A., Dostmann, W. R. G., and Taylor, S. S. (1991) Biochemistry 30, 3035-3040 [CrossRef][Medline] [Order article via Infotrieve]
  29. Zoller, M. J., and Taylor, S. S. (1979) J. Biol. Chem. 254, 8363-8368 [Free Full Text]
  30. Landschulz, W. H., Johnson, P. F., and McKnight, S. L. (1988) Science 240, 1759-1764 [Abstract/Free Full Text]
  31. Harbury, P. B., Zhang, T., Kim, P. S., and Alber, T. (1993) Science 262, 1401-1407 [Abstract/Free Full Text]
  32. Takio, K., Smith, S. B., Krebs, E. G., Walsh, K. A., and Titani, K. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 2544-2548 [Abstract/Free Full Text]
  33. Titani, K., Shoji, S., Ericsson, L. H., Walsh, K. A., Neurath, H., Fischer, E. H., Takio, K., Smith, S. B., Krebs, E. G., and Demaille, J. G. (1981) in Protein Phosphorylation (Rosen, O. M., and Krebs, E. G., eds), pp. 19-32, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  34. Garnier, J., Osguthorpe, D. J., and Robson, B. (1978) J. Mol. Biol. 120, 97-120 [CrossRef][Medline] [Order article via Infotrieve]
  35. Sarkar, D., Erlichman, J., and Rubin, C. S. (1984) J. Biol. Chem. 259, 9840-9846 [Abstract/Free Full Text]
  36. Theurkauf, W. E., and Vallee, R. B. (1982) J. Biol. Chem. 257, 3284-3289 [Free Full Text]
  37. Lohmann, S. M., DeCamilli, P., Einig, I., and Walter, U. (1984) Proc. Natl. Acad. Sci. U. S. A. 81, 6723-6727 [Abstract/Free Full Text]
  38. Carr, D. W., Hausken, Z. E., Fraser, I. D. C., Stofko-Hahn, R. E., and Scott, J. D. (1992) J. Biol. Chem. 267, 13376-13382 [Abstract/Free Full Text]
  39. Hausken, Z. E., Dell'Acqua, M. L., Coghlan, V. M., and Scott, J. D. (1996) J. Biol. Chem. 271, 29016-29022 [Abstract/Free Full Text]
  40. Hausken, Z. E., Coghlan, V. M., Hastings, C. A., Reimann, E. M., and Scott, J. D. (1994) J. Biol. Chem. 269, 24245-24251 [Abstract/Free Full Text]
  41. Luo, Z., Shafit-Zagardo, B., and Erlichman, J. (1990) J. Biol. Chem. 265, 21804-21810 [Abstract/Free Full Text]
  42. Carr, D. W., Stofko-Hahn, R. E., Fraser, I. D. C., Bishop, S. M., Acott, T. S., Brennan, R. G., and Scott, J. D. (1991) J. Biol. Chem. 266, 14188-14192 [Abstract/Free Full Text]
  43. Carr, D. W., Stofko-Hahn, R. E., Fraser, I. D. C., Cone, R. D., and Scott, J. D. (1992) J. Biol. Chem. 267, 16816-16823 [Abstract/Free Full Text]
  44. Li, Y., and Rubin, C. S. (1995) J. Biol. Chem. 270, 1935-1944 [Abstract/Free Full Text]
  45. Monken, C. E., and Gill, G. N. (1980) J. Biol. Chem. 255, 7067-7070 [Abstract/Free Full Text]
  46. Landgraff, W., Hofmann, F., Pelton, J. T., and Higgins, J. P. (1990) Biochemistry 29, 9921-9928 [CrossRef][Medline] [Order article via Infotrieve]
  47. Atkinson, R. A., Saudek, V., Huggins, J. P., and Pelton, J. T. (1991) Biochemistry 30, 9387-9385 [CrossRef][Medline] [Order article via Infotrieve]
  48. Monken, C. E., and Gill, G. N. (1985) Arch. Biochem. Biophys. 240, 888-903 [CrossRef][Medline] [Order article via Infotrieve]

Volume 272, Number 45, Issue of November 7, 1997 pp. 28431-28437
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
J. P. Brennan, S. C. Bardswell, J. R. Burgoyne, W. Fuller, E. Schroder, R. Wait, S. Begum, J. C. Kentish, and P. Eaton
Oxidant-induced Activation of Type I Protein Kinase A Is Mediated by RI Subunit Interprotein Disulfide Bond Formation
J. Biol. Chem., August 4, 2006; 281(31): 21827 - 21836.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
L. L. Burns-Hamuro, Y. Hamuro, J. S. Kim, P. Sigala, R. Fayos, D. D. Stranz, P. A. Jennings, S. S. Taylor, and V. L. Woods Jr.
Distinct interaction modes of an AKAP bound to two regulatory subunit isoforms of protein kinase A revealed by amide hydrogen/deuterium exchange
Protein Sci., December 1, 2005; 14(12): 2982 - 2992.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. TASKEN and E. M. AANDAHL
Localized Effects of cAMP Mediated by Distinct Routes of Protein Kinase A
Physiol Rev, January 1, 2004; 84(1): 137 - 167.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Richie-Jannetta, S. H. Francis, and J. D. Corbin
Dimerization of cGMP-dependent Protein Kinase I{beta} Is Mediated by an Extensive Amino-terminal Leucine Zipper Motif, and Dimerization Modulates Enzyme Function
J. Biol. Chem., December 12, 2003; 278(50): 50070 - 50079.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. E. Martinez, A. Y. Wu, N. A. Glavas, X.-B. Tang, S. Turley, W. G. J. Hol, and J. A. Beavo
The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding
PNAS, October 1, 2002; 99(20): 13260 - 13265.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
M. Saudohar, M. Bencina, P. J.I van de Vondervoort, H. Panneman, M. Legisa, J. Visser, and G. J. G. Ruijter
Cyclic AMP-dependent protein kinase is involved in morphogenesis of Aspergillus niger
Microbiology, August 1, 2002; 148(8): 2635 - 2645.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Barradeau, T. Imaizumi-Scherrer, M. C. Weiss, and D. M. Faust
Muscle-regulated expression and determinants for neuromuscular junctional localization of the mouse RIalpha regulatory subunit of cAMP- dependent protein kinase
PNAS, April 5, 2001; (2001) 81393598.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
R. G. Angelo and C. S. Rubin
Characterization of Structural Features That Mediate the Tethering of Caenorhabditis elegans Protein Kinase A to a Novel A Kinase Anchor Protein. INSIGHTS INTO THE ANCHORING OF PKAI ISOFORMS
J. Biol. Chem., February 11, 2000; 275(6): 4351 - 4362.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Miki and E. M. Eddy
Single Amino Acids Determine Specificity of Binding of Protein Kinase A Regulatory Subunits by Protein Kinase A Anchoring Proteins
J. Biol. Chem., October 8, 1999; 274(41): 29057 - 29062.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Banky, L. J.-S. Huang, and S. S. Taylor
Dimerization/Docking Domain of the Type Ialpha Regulatory Subunit of cAMP-dependent Protein Kinase. REQUIREMENTS FOR DIMERIZATION AND DOCKING ARE DISTINCT BUT OVERLAPPING
J. Biol. Chem., December 25, 1998; 273(52): 35048 - 35055.
[Abstract] [Full Text] [PDF]


Home page